BEMO:2000056 · BEMO metric v1.0.0
Susceptibility/Risk Biomarker Validity
The probability or degree that susceptibility/risk biomarker validity introduces systematic distortion into a biomedical estimate or conclusion.
- Scientific pillar
- External Validity, Biomarkers, and Clinical Evidence
- Source category
- Biomarker and Endpoint Validation
- Output scale
- RiskScale
- Source maturity
- Mature
Scientific meaning
What it measures
Assesses susceptibility/risk biomarker validity using evidence appropriate to biomarker and endpoint validation, distinguishing random uncertainty from systematic error.
Why it matters
Material weakness in susceptibility/risk biomarker validity can change the direction, magnitude, certainty, or biological interpretation of the research conclusion.
Measurement criteria
Prespecified signaling questions; direction and likely magnitude of distortion; domain-level and overall judgment; sensitivity to plausible bias.
Typical methods of assessment
Structured critical appraisal; quantitative estimation with uncertainty; prespecified thresholds; independent replication; sensitivity and subgroup analyses.
Computation profile
- Computation mode
- RiskAssessmentComputation
- Readiness
- RubricOrModelRequired
- Formula status
- ContextSpecificProtocolRequired
- Method family
- risk assessment or calibrated probability estimation
- Output datatype
- xsd:string_or_decimal
- Unit or scale
- Ordinal risk rating or quantitative percentage/probability; lower is generally better
- Numeric range
- Context dependent
- Directionality
- LowerIsBetter
Required inputs
- risk_factors
- assessment_context
- rubric_or_model_version
- evidence_records
Optional inputs
- weights
- thresholds
- calibration_dataset
Machine-readable expression
{
"language": "BEMO-Expression-JSON",
"operator": "external_protocol",
"protocolRef": "REQUIRED",
"allowed_outputs": [
"ordinal_risk_category",
"probability",
"percentage"
]
}Computation policies
- Aggregation
- Not specified in source; must be defined and versioned before composite use.
- Normalization
- None by default; any normalization must be justified, versioned, and validated.
- Missing data
- Must be declared before computation; report missingness; no silent imputation; perform sensitivity analysis when material.
- Uncertainty required
- Yes
- Uncertainty method
- Confidence interval, credible interval, bootstrap distribution, inter-rater reliability, or sensitivity analysis as scientifically applicable.
- Confidence interval required
- Yes
- Threshold policy
- Prespecify, justify, version, and sensitivity-test thresholds; do not derive and evaluate on the same data without correction.
- Decision thresholds
- No universal threshold declared
- Quality control
- Source provenance; input validation; duplicate control; uncertainty reporting; independent or orthogonal validation where applicable.
- Calibration
- Required for probability outputs; rubric reliability required for ordinal outputs.
Applicability and validation
- Evidence object
- Result / experiment / study / body of evidence, as applicable
- Evidence level
- Result / experiment / study / body of evidence, as applicable
- Study types
- Biomarker development, qualification, endpoint and surrogate validation studies
- Domain
- Biomarker and Endpoint Validation
- Required data sources
- Context-specific; use source references, registered studies, primary data, and authoritative biomedical resources as applicable.
- Validation status
- Source maturity: Mature; BEMO computation profile requires independent validation.
- Benchmark
- A representative, versioned benchmark set is required before production use.
- Reference standard
- Use an independent reference standard when one exists; document expert-adjudicated alternatives.
- External validation required
- Yes
Interpretation safeguards
Common misinterpretations
Treating susceptibility/risk biomarker validity as interchangeable with overall study quality, or interpreting a favorable value as proof that all other bias and validity domains are satisfactory.
Limitations
Depends on context, operational definition, thresholds, data quality, and evaluator judgment; it should not be used as a stand-alone summary score without domain-level evidence.
Dependency status
Not yet curated. Closely related metrics are represented; causal or computational dependencies require expert curation.
Source provenance
- Source workbook
- Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx
- Source worksheet
- Biomedical Evidence Metrics
- Source row
- 63
- Source record SHA-256
596927f557190db71a0b686158bde6134cafa9cdb9c1876784270d91a80452f5- Definition source
- Pure_Biomedical_Evidence_Research_Metrics_Part_2(3).xlsx row 63; see source_references
- Ontology IRI
- https://w3id.org/bemo/BEMO_2000056
- Profile IRI
- https://w3id.org/bemo/profile/BEMO_2000056
Scientific references (4)
- https://www.fda.gov/media/119271/downloadSource framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.ncbi.nlm.nih.gov/books/NBK326791/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.ema.europa.eu/en/ich-e16-genomic-biomarkers-related-drug-response-context-structure-format-qualification-submissions-scientific-guidelineSource framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
- https://www.equator-network.org/reporting-guidelines/reporting-recommendations-for-tumor-marker-prognostic-studies-remark/Source framework, standard, guideline, or originSource-preserved; URL reachability not asserted by this package
Governance and FAIR status
- Lifecycle
- Candidate
- Approval
- Draft
- Owner
- BEMO Project
- Curator
- Unassigned
- Reviewer
- Unassigned
- License
- Pending owner approval; CC BY 4.0 recommended for OBO compatibility.
- Findable
- Provisional: stable local ID assigned; public namespace registration pending.
- Accessible
- Provisional: package is distributable; permanent public release location pending.
- Interoperable
- Yes: OWL 2, RDF, SKOS, SHACL, JSON-LD, CSV, and OBO-style identifiers.
- Reusable
- Provisional: rich metadata supplied; open-license owner approval pending.
- Governance note
- Candidate term pending scientific, ontology-engineering, and computation-method review.
- Editor note
- Source content preserved verbatim; computation metadata is a generated default and must be curated before normative use.